Esomeprazole magnesium enteric-coated pellet-based tablets with high acid tolerance and good compressibility

다국어 초록 (Multilingual Abstract)

The aim of this study was to develop esomeprazole magnesium (EMZ-Mg) enteric-coated pellets and pellet-based tablets, as well as to investigate the effects of pellet size and compression method on acid tolerance, content uniformity, compressibility, and stability of preparations.
This study used two types of pellet cores, namely, microcrystalline cellulose (MCC) core with a particle size of 150–300 μm and sucrose core with a particle size of 600–700 μm. Enteric-coated pellets, which consisted of a drug-free core, a drug layer, a sub-coating layer (hydroxypropyl methylcellulose, 6 cps), and an enteric-coating layer ( Eudragit®L30D-55), were prepared by using a bottomspray fluidized bed-coating technique. Pellet-based tablets were prepared by using a direct compression method or a wet granulation method. The acid tolerances of the two types of enteric-coated pellets (MCC and sucrose cores) reached up to 98% in simulated gastric fluid (pH 1.0) within 2 h, and the dissolution rates in simulated intestinal fluid (pH 6.8) reached up to 85% of the labeled amount within 15 min. When compressed into tablets, the pellets based on MCC core (smaller particle size) displayed a significantly higher acid tolerance (up to 92%) compared with the pellets based on sucrose core (larger particle size). In addition, the MCC core-based tablets (F8), especially those prepared by using a granulation method, showed higher drug content uniformity and compressibility than the sucrose core-based tablets (F10), and no lamination phenomenon was observed during compression. The crystallinity of EMZ-Mg was altered during drug layering process, and some physicochemical interactions were observed between the drug and excipients. Moreover, the two types of enteric-coated pellets showed a relatively high stability after storage under high temperature and strong light. However, they showed poor stability under high humidity, resulting in remarkable degradation of active compound. The EMZ-Mg entericcoated pellets and pellet-based tablets were successfully developed, and reduction in pellet size and wet granulation reduced the differences in content uniformity and better protected the pellet coating from damages during compression.

참고문헌 (Reference)

1 Turkoglu M, "Tableting and stability evaluation of enteric-coated omeprazole pellets" 57 (57): 279-286, 2004

2 Ghanam D, "Suitability of kappa-carrageenan pellets for the formulation of multiparticulate tablets with modified release" 409 (409): 9-18, 2011

3 Liu Z, "Novel application method of talcum powder to prevent sticking tendency and modify release of esomeprazole magnesium enteric-coated pellets" 21 (21): 405-414, 2016

4 Park HJ, "Multiple-unit tablet of probiotic bacteria for improved storage stability, acid tolerability, and in vivo intestinal protective effect" 10 : 1355-1364, 2016

5 Rujivipat S, "Moisture plasticization for enteric Eudragit(R) L30D-55-coated pellets prior to compression into tablets" 81 (81): 223-229, 2012

6 Gaber DM, "Mini-tablets versus pellets as promising multiparticulate modified release delivery systems for highly soluble drugs" 488 (488): 86-94, 2015

7 Dukic-Ott A, "In-vitro and in-vivo evaluation of enteric-coated starchbased pellets prepared via extrusion/spheronisation" 70 (70): 302-312, 2008

8 Alhusban F, "Formulation of multiparticulate systems as lyophilised orally disintegrating tablets" 79 (79): 627-634, 2011

9 Zeeshan F, "Exploring the potential of a highly compressible microcrystalline cellulose as novel tabletting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drug" 10 (10): 850-857, 2009

10 Kucera SU, "Evaluation of Ceolus microcrystalline cellulose grades for the direct compression of enteric-coated pellets" 38 (38): 341-350, 2012

11 Marvola M, "Effect of dosage form and formulation factors on the adherence of drugs to the esophagus" 72 (72): 1034-1036, 1983

12 Mehta S, "Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules" 422 (422): 310-317, 2012

13 Hosseini A, "Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile" 457 (457): 503-509, 2013

14 Wagner KG, "Development of disintegrating multiple-unit tablets on a high-speed rotary tablet press" 50 (50): 285-292, 2000

15 Varshosaz J, "Development and evaluation of a novel pellet-based tablet system for potential colon delivery of budesonide" 2012 : 905191-, 2012

16 Zeeshan F, "Development and evaluation of a novel modified-release pellet-based tablet system for the delivery of loratadine and pseudoephedrine hydrochloride as model drugs" 11 (11): 910-916, 2010

17 Sandberg A, "Design of a new multiple-unit controlled-release formulation of metoprolol-metoprolol CR" 33 : S3-S7, 1988

18 Debunne A, "Compaction of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation" 22 (22): 305-314, 2004

19 Wang J, "An evaluation of process parameters to improve coating efficiency of an active tablet film-coating process" 427 (427): 163-169, 2012

20 Bertolini T, "A novel automated hydrophilic interaction liquid chromatography method using diode-array detector/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceuticals" 1365 : 131-139, 2014

21 Davitt CJ, "A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens" 233 : 162-173, 2016

22 Yang Z, "A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets" 21 (21): 943-950, 2016